EIF4E and cervical cancer: Further, because eIF4E phosphorylation is related to chemotherapy resistance in several gynecological malignancies, particularly DNA‐damaging agents [35, 36], concomitant treatment with pharmacological inhibitors of eIF4E could meaningfully improve the survival rate of patients with relapsed cervical cancer exhibiting chemotherapy resistance.